Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A patient with complete hair loss regrew all her hair using tofacitinib.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Online articles about alopecia areata are too hard to understand and need to be clearer.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.